ACLARUBICIN HYDROCHLORIDE
- CAS NO.:75443-99-1
- Empirical Formula: C42H54ClNO15
- Molecular Weight: 848.33
- MDL number: MFCD00133024
- EINECS: 278-209-3
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-07-02 08:55:03
What is ACLARUBICIN HYDROCHLORIDE?
Definition
ChEBI: Aclarubicin hydrochloride is an anthracycline.
Biological Activity
Aclacinomycin A hydrochloride (Aclarubicin hydrochloride) is a fluorescent molecule and the first non-peptidic inhibitor discovered to have discrete specificity for the CTRL (chymotrypsin-like) activity of the 20S proteasome. It is also a dual inhibitor of topoisomerase I and II (topoisomerase I and II). It is an effective anthracycline chemotherapeutic agent for blood cancer and solid tumor related research.
in vitro
Aclacinomycin A could efficiently enter living cells and emit fluorescence in situ . Aclacinomycin A (10 μM for 15 min) is sufficient for clear detection of fluorescence in most of the cultured cells. Aclacinomycin A treatment (10 μM Acla for 15 min) results in approximately 20% dead (or nearly dead) cells.
Aclacinomycin A (Aclarubicin) effectively induces incorporation of exon 7 into SMN2 transcripts from the endogenous gene in type I SMA fibroblasts as well as into transcripts from a SMN2 minigene in the motor neuron cell line NSC34 .
in vivo
Aclarubicin hydrochloride(Aclacinomycin A) is very well absorbed in mice, rats, and dogs after its oral administration. The oral LD 50 (76.5 mg/kg) is about twice the iv LD 50 (35.6 mg/kg) in mice [4 .
Aclacinomycin A ( 0.75-6 mg/kg, ip daily) dose-dependently exhibits tumor growth in mice-based Leukemia P-388 model [4 .
Animal Model: | DBA/2, CDF 1 ( BALB/c×DBA/2) mice with Leukemia P-388 [4 . | tr>
Dosage: | 0.75 mg/kg, 1.5 mg/kg, 3 mg/kg, 6 mg/kg. | td>
Administration: | Intraperit oneal administration daily for 10 days starting 3 hr after transplantation. |
Result: | Inhibited tumor growth. |
Properties of ACLARUBICIN HYDROCHLORIDE
Melting point: | 151-153℃ |
Boiling point: | 898℃ |
Flash point: | >110°(230°F) |
storage temp. | 2-8°C |
solubility | Soluble in DMSO or DMF at 25mg/ml |
form | Solid |
color | Light yellow to yellow |
Safety information for ACLARUBICIN HYDROCHLORIDE
Pictogram(s) |
Skull and Crossbones Acute Toxicity GHS06 |
GHS Hazard Statements |
H301:Acute toxicity,oral H311:Acute toxicity,dermal H331:Acute toxicity,inhalation |
Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P304+P340:IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. P405:Store locked up. |
Computed Descriptors for ACLARUBICIN HYDROCHLORIDE
New Products
6-Bromo 2-Iodo Indole Pyridine 2,4,6-Tricarboxaldehyde Fosfomycin EP impurity D Rimegepant Impurity 3 Ivermectin EP Impurity B Tubulysin H Tubulysin D Tubulysin G (2S,4R)-4-amino-2-methyl-5-phenylpentanoic acid hydrochloride Tubulysin F 2,2-diethoxyethanethioamide Imeglimin Hydrochloride IH Calcium Sodium Phosphosilicate IH 2-[[(3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]ethanol ethanedioate 2-(1-(Mercaptomethyl) cyclopropyl) acetonitrile (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine Fuel shell 4,7-Dibromobenzo[c][1,2,5]thiadiazole-5,6-diamine Methyl 4-amino-3-(4-phenylpiperazin-1-yl)benzoate Methyl 4-amino-3-(piperidin-1-yl)benzoate Diethyl 2,5-di(furan-2-yl)terephthalate 2-(4-Bromopyridin-2-yl)acetonitrile 3,6-Bis(4-iodophenyl)-2,5-dihydropyrrolo[3,4-c]pyrrole-1,4-dione 2-chloro-N-(biphenyl-2-yl) nicotinamideRelated products of tetrahydrofuran
You may like
-
3,6-Bis(4-iodophenyl)-2,5-dihydropyrrolo[3,4-c]pyrrole-1,4-dioneView Details
952145-70-9 -
1262243-12-8View Details
1262243-12-8 -
Rimegepant Impurity 3View Details
-
Sidchem 730View Details
-
Sidchem BT 20View Details
-
1572177-89-9View Details
1572177-89-9 -
6390-09-6View Details
6390-09-6 -
6-Bromo indoleView Details